MCSLF (McMillan Shakespeare) YoY EBITDA Growth: 16.87% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MCSLF McMillan Shakespeare Ltd MCSLF
78 GF Score
Price $9.90
GF Value $12.57
! 13 Warning Signs
View Full Analysis

What is McMillan Shakespeare YoY EBITDA Growth?

McMillan Shakespeare MCSLF 78 YoY EBITDA Growth is 16.87% as of Dec. 2025. GuruFocus rates MCSLF with a GF Score™ of 78/100 and a GF Value™ of $12.57. The stock has 13 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. McMillan Shakespeare's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 16.87%.

McMillan Shakespeare's EBITDA per Share for the six months ended in Dec. 2025 was $1.25.

McMillan Shakespeare YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for McMillan Shakespeare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

McMillan Shakespeare YoY EBITDA Growth Chart

McMillan Shakespeare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.69 -8.26 0.19 36.14 7.45

McMillan Shakespeare Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.29 44.90 3.77 7.50 16.87
MCSLF
78GF Score
McMillan Shakespeare Ltd MCSLF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

McMillan Shakespeare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

McMillan Shakespeare's YoY EBITDA Growth for the fiscal year that ended in Jun. 2025 is calculated as:

YoY EBITDA Growth (A: Jun. 2025 )
=(EBITDA per Share (A: Jun. 2025 )-EBITDA per Share (A: Jun. 2024 ))/ | EBITDA per Share (A: Jun. 2024 ) |
=(2.279-2.121)/ | 2.121 |
=7.45 %

McMillan Shakespeare's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(1.254-1.073)/ | 1.073 |
=16.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 16.87% mean?
McMillan Shakespeare (MCSLF) has a YoY EBITDA Growth of 16.87% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for McMillan Shakespeare and its competitors.
Is McMillan Shakespeare's YoY EBITDA Growth too high?
McMillan Shakespeare's current YoY EBITDA Growth is 16.87%. Overall, McMillan Shakespeare has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does McMillan Shakespeare's YoY EBITDA Growth compare to KFY and RHI?
McMillan Shakespeare's YoY EBITDA Growth of 16.87% can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Business Services company?
A good YoY EBITDA Growth depends on the Business Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for McMillan Shakespeare and its competitors. McMillan Shakespeare's current YoY EBITDA Growth is 16.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McMillan Shakespeare stock overvalued right now?
McMillan Shakespeare (MCSLF) has a current YoY EBITDA Growth of 16.87%. The stock's GF Value™ is $12.57, compared to a current price of $9.90 — trading 21.2% below its estimated fair value. The current YoY EBITDA Growth is 16.87%. McMillan Shakespeare's overall GF Score™ is 78/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For McMillan Shakespeare (MCSLF), the current YoY EBITDA Growth is 16.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is McMillan Shakespeare (MCSLF) Overvalued in 2026?

Based on GuruFocus' analysis, McMillan Shakespeare stock appears to be undervalued. The current stock price of $9.90 is trading 21.2% below its estimated GF Value™ of $12.57.

Key valuation signals for MCSLF:

  • YoY EBITDA Growth: 16.87%
  • GF Value™: $12.57 vs. price of $9.90 (21.2% below fair value)
  • GF Score™: 78/100 with 13 warning signs

No single metric tells the full story. See the MCSLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

McMillan Shakespeare Business Description

Other Exchanges NMN:GermanyMMS:Australia
Address 360 Elizabeth Street, Level 21, The Tower, Melbourne Central, Melbourne, VIC, AUS, 3000
McMillan Shakespeare is a provider of salary packaging, novated leasing, disability plan management and support co-ordination, and fleet management services. It actively works to cross-sell its products to clients, for example, selling its salary packaging services to its fleet management customers in Australia and New Zealand. McMillan dominates Australia's salary packaging market together with Smartgroup (also covered by Morningstar), and is also a large provider of novated leasing services by volumes—together with Smartgroup and SG Fleet. The group has three operating segments: group remuneration services, asset management services, and plan and support services. Most of the group's revenue is generated from the group remuneration services segment.
78GF Score

Get the complete analysis for MCSLF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.90
Price
$12.57
GF Value